The Recall Desk
SevereFDA (Drugs)·D-0360-2015·Announced 2015-01-28

Walgreens Recalls Tigecycline Infusions Due to Sterility Concerns

Walgreens Infusion Services is recalling Tigecycline in normal saline due to a lack of sterility assurance. The products were distributed in six southern states.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a significant hazard such as lack of sterility assurance in an infusion product warrants a 'Severe' rating (Score 4), as it poses a risk of serious injury or infection, even if specific hospitalization reports are not detailed in the provided text.

Plain-English summary

Walgreens Infusion Services is recalling various strengths of Tigecycline in normal saline. The recall was initiated because of a lack of sterility assurance in the products.

The affected products were distributed in Texas, Florida, Virginia, Georgia, Louisiana, and Mississippi. The source text indicates that all products within their expiry dates are included in this recall.

Consumers and healthcare providers should stop using the recalled products and contact their healthcare provider or the recalling firm for further instructions.

The recalled product

Product
Tigecycline various strengths in normal saline

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All products within expiry.

Distribution

Distributed in 6 states:

Part of a larger recall action

This product is one of 36 recalled by Walgreens Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 36 products in this recall →